Sec. 3. Research on dioxin and other potentially harmful components of feminine hygiene products
300 words·~1 min read·
/bill/113/hr/4746/ih/section-3A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
Part F of title IV of the Public Health Service Act ( 42 U.S.C. 287d et seq. ) is amended by adding at the end the following section: The Director of NIH, in collaboration with the Director of the Office, shall provide for the conduct or support of research to determine the extent to which the presence of dioxins, synthetic fibers, chlorine, and other components, including contaminants and substances used as fragrances, in tampons and other feminine hygiene products— poses any risks to the health of women who use the products, including risks relating to cervical cancer, endometriosis, infertility, ovarian cancer, breast cancer, immune system deficiencies, pelvic inflammatory disease, toxic shock syndrome, and bacterial and yeast infections; and poses any risks to the health of children of women who used such products during or before the pregnancies involved, including risks relating to fetal and childhood development.
Research under paragraph
(1)shall include research to confirm the data on tampons and other feminine hygiene products submitted to the Commissioner of Food and Drugs by manufacturers of such products. For purposes of paragraph (1), the term feminine hygiene products means tampons, pads, liners, cups, sponges, and similar products used by women with respect to menstruation or other genital-tract secretions. Reports on the results of research under subsection
(a)shall be periodically submitted to the Congress, the Commissioner of Food and Drugs, the Administrator of the Environmental Protection Agency, and the Chairman of the Consumer Product Safety Commission. Such reports shall be made available to the public through the data system and clearinghouse program established under section 486A, or through other appropriate means. For the purpose of carrying out this section, there are authorized to be appropriated such sums as may be necessary for each of the fiscal years 2015 through 2019. .
Connectionstraces to 1
Traces to 1 document
Citation graph
cites case law
Sec. 3
Research on dioxin and other potentially harmful components of feminine hygiene products
Cites 1Cited by 0 across 0 sources